VHL Inactivation: A New Road to Senescence

Slides:



Advertisements
Similar presentations
Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Advertisements

Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells Nilay Sethi, Xudong Dai, Christopher.
Eph-Ephrin Bidirectional Signaling in Physiology and Disease Elena B. Pasquale Cell Volume 133, Issue 1, Pages (April 2008) DOI: /j.cell
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics Carlos L. Arteaga, Jeffrey A. Engelman Cancer Cell Volume.
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia Tim C.P. Somervaille, Michael L. Cleary Cancer Cell.
Modeling Inducible Human Tissue Neoplasia Identifies an Extracellular Matrix Interaction Network Involved in Cancer Progression Jason A. Reuter, Susana.
Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung Zvi Granot, Erik Henke, Elizabeth A. Comen, Tari A. King, Larry Norton, Robert Benezra.
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
A Conditional Mouse Model of Synovial Sarcoma: Insights into a Myogenic Origin Malay Haldar, Jeffrey D. Hancock, Cheryl M. Coffin, Stephen L. Lessnick,
Inflammation and Cancer: IL-6 and STAT3 Complete the Link
The Kinase-Independent, Second Life of CDK6 in Transcription
Volume 7, Issue 3, Pages (March 2005)
Cancer: Inappropriate Expression of Stem Cell Programs?
Charles Swanton, Julian Downward  Cancer Cell 
David Largaespada, Nancy Ratner  Cancer Cell 
NF-κB: A Coordinator for Epigenetic Regulation by MLL
CD5: A New Partner for IL-6
Joseph E. Druso, Claudia Fischbach  Trends in Cancer 
Metastasis gets site specific
mTOR Signaling in Melanoma: Oncogene-Induced Pseudo-Senescence?
HSF1 in Translation Cancer Cell
Volume 11, Issue 4, Pages (April 2007)
RAS unplugged: Negative feedback and oncogene-induced senescence
Three Down and One To Go: Modeling Medulloblastoma Subgroups
Actin and Microtubules: Working Together to Control Spindle Polarity
Annapoorni Rangarajan, Sue J. Hong, Annie Gifford, Robert A. Weinberg 
Senescence: Not Just for Tumor Suppression
DAISY: Picking Synthetic Lethals from Cancer Genomes
Deregulating EMT and Senescence: Double Impact by a Single Twist
Volume 26, Issue 1, Pages 1-2 (July 2014)
T.S. Karin Eisinger-Mathason, M. Celeste Simon  Cancer Cell 
Kidney Cancer: Now Available in a New Flavor
A Radical Role for p38 MAPK in Tumor Initiation
CALming Down T Cell Acute Leukemia
PICS-ure This: Prosenescence Therapy?
Taking the Study of Cancer Cell Survival to a New Dimension
The p27Kip1 tumor suppressor gene: Still a suspect or proven guilty?
Raf-1 and Squamous Cell Carcinoma: Rok-ing the Boat
The great MYC escape in tumorigenesis
Deregulating EMT and Senescence: Double Impact by a Single Twist
Richard G. Carroll, Seamus J. Martin  Cancer Cell 
The RAF Inhibitor Paradox Revisited
FAL1ing inside an Amplicon
Cancer Metabolism: Is Glutamine Sweeter than Glucose?
Tumor Suppression by p53: Fall of the Triumvirate?
Frances Balkwill, Kellie A. Charles, Alberto Mantovani  Cancer Cell 
LKB1 and Src: Antagonistic Regulators of Tumor Growth and Metastasis
Hard Times for Oncogenic BRAF-Expressing Melanoma Cells
BMPing Off Glioma Stem Cells
NO Signals from the Cancer Stem Cell Niche
John D. Gordan, Craig B. Thompson, M. Celeste Simon  Cancer Cell 
Volume 14, Issue 4, Pages (October 2008)
Volume 16, Issue 3, Pages (September 2009)
A common pathway for genetic events leading to pheochromocytoma
Khalid S. Mohammad, Theresa A. Guise  Cancer Cell 
Under Pressure: Stromal Fibroblasts Change Their Ways
To Infinium, and Beyond! Cancer Cell
FAL1ing inside an Amplicon
Volume 10, Issue 3, Pages (September 2006)
All Roads Lead to the Ribosome
Co-opted integrin signaling in ErbB2-induced mammary tumor progression
ROS: Really involved in Oxygen Sensing
Glycogen Synthase Kinase-3 and Cancer: Good Cop, Bad Cop?
Is Cyclin D1-CDK4 kinase a bona fide cancer target?
Connecting with an Old Partner in a New Way
Kidney Cancer: Now Available in a New Flavor
Anthony N. Imbalzano, Stephen N. Jones  Cancer Cell 
The Ups and Downs of Src Regulation: Tumor Suppression by Cbp
Turning Reciprocal Feedback Regulation into Combination Therapy
Senescence Elicits Stemness: A Surprising Mechanism for Cancer Relapse
Presentation transcript:

VHL Inactivation: A New Road to Senescence William Y. Kim, Norman E. Sharpless  Cancer Cell  Volume 13, Issue 4, Pages 295-297 (April 2008) DOI: 10.1016/j.ccr.2008.03.012 Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 1 pVHL Inactivation Results in Both Pro- and Antitumorgenic Effects pVHL loss induces both oncogenic signals and tumor suppressive responses. Oncogenic sequelae of pVHL inactivation include Jun-B-dependent inhibition of neuronal apoptosis, destabilization of microtubules, defective assembly of the extracellular matrix (ECM), p53 inactivation, and the upregulation of HIF. HIF stabilization results in the transactivation of protumorigenic genes including VEGF, PDGF, and TGFα. Kaelin and colleagues now show that pVHL loss also suppresses p400, resulting in p27KIP and pRb activation and promotion of the tumor suppressive response, cellular senescence. Cancer Cell 2008 13, 295-297DOI: (10.1016/j.ccr.2008.03.012) Copyright © 2008 Elsevier Inc. Terms and Conditions